Assessing variants of uncertain significance implicated in hearing loss using a comprehensive deafness proteome.
Human Genetics
Tollefson, Mallory R MR; Gogal, Rose A RA; Weaver, A Monique AM; Schaefer, Amanda M AM; Marini, Robert J RJ; Azaiez, Hela H; Kolbe, Diana L DL; Wang, Donghong D; Weaver, Amy E AE; Casavant, Thomas L TL; Braun, Terry A TA; Smith, Richard J H RJH; Schnieders, Michael J MJ
Publication Date: 2023-04-22
Variant appearance in text: FGFR3: 1108G>T; Gly370Cys
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Jang, H Josh HJ; Hostetter, Galen G; MacFarlane, Alexander W AW; Madaj, Zachary Z; Ross, Eric A EA; Hinoue, Toshinori T; Kulchycki, Justin R JR; Burgos, Ryan S RS; Tafseer, Mahvish M; Alpaugh, R Katherine RK; Schwebel, Candice L CL; Kokate, Rutika R; Geynisman, Daniel M DM; Zibelman, Matthew R MR; Ghatalia, Pooja P; Nichols, Peter W PW; Chung, Woonbok W; Madzo, Jozef J; Hahn, Noah M NM; Quinn, David I DI; Issa, Jean-Pierre J JJ; Topper, Michael J MJ; Baylin, Stephen B SB; Shen, Hui H; Campbell, Kerry S KS; Jones, Peter A PA; Plimack, Elizabeth R ER
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.
Esmo Open
Murugesan, K K; Necchi, A A; Burn, T C TC; Gjoerup, O O; Greenstein, R R; Krook, M M; López, J A JA; Montesion, M M; Nimeiri, H H; Parikh, A R AR; Roychowdhury, S S; Schwemmers, S S; Silverman, I M IM; Vogel, A A
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.
American Journal Of Human Genetics
Pejaver, Vikas V; Byrne, Alicia B AB; Feng, Bing-Jian BJ; Pagel, Kymberleigh A KA; Mooney, Sean D SD; Karchin, Rachel R; O'Donnell-Luria, Anne A; Harrison, Steven M SM; Tavtigian, Sean V SV; Greenblatt, Marc S MS; Biesecker, Leslie G LG; Radivojac, Predrag P; Brenner, Steven E SE; ,
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression.
Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Sternberg, Cora N CN; Petrylak, Daniel P DP; Bellmunt, Joaquim J; Nishiyama, Hiroyuki H; Necchi, Andrea A; Gurney, Howard H; Lee, Jae-Lyun JL; van der Heijden, Michiel S MS; Rosenbaum, Eli E; Penel, Nicolas N; Pang, See-Tong ST; Li, Jian-Ri JR; García Del Muro, Xavier X; Joly, Florence F; Pápai, Zsuzsanna Z; Bao, Weichao W; Ellinghaus, Peter P; Lu, Chengxing C; Sierecki, Mitchell M; Coppieters, Sabine S; Nakajima, Keiko K; Ishida, Tatiane Cristine TC; Quinn, David I DI
The mutational landscape of cancer's vulnerability to ionizing radiation.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Gopal, Priyanka P; Yard, Brian D BD; Petty, Aaron A; Lal, Jessica C JC; Bera, Titas K TK; Hoang, Trung Q TQ; Buhimschi, Alexandru B AB; Abazeed, Mohamed E ME
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.
Nature Communications
Vo, Josh N JN; Wu, Yi-Mi YM; Mishler, Jeanmarie J; Hall, Sarah S; Mannan, Rahul R; Wang, Lisha L; Ning, Yu Y; Zhou, Jin J; Hopkins, Alexander C AC; Estill, James C JC; Chan, Wallace K B WKB; Yesil, Jennifer J; Cao, Xuhong X; Rao, Arvind A; Tsodikov, Alexander A; Talpaz, Moshe M; Cole, Craig E CE; Ye, Jing C JC; , ; Bergsagel, P Leif PL; Auclair, Daniel D; Cho, Hearn Jay HJ; Robinson, Dan R DR; Chinnaiyan, Arul M AM
Publication Date: 2022-06-29
Variant appearance in text: FGFR3: 1108G>T; Gly370Cys; rs121913479
PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study.
Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Grantzau, Trine T; Toft, Birgitte Grønkaer BG; Melchior, Linea Cecilie LC; Elversang, Johanna J; Stormoen, Dag Rune DR; Omland, Lise Høj LH; Pappot, Helle H
Fibroblast growth factor receptor 3 gene (FGFR3) mutations in high-grade muscle-invasive urothelial bladder cancer in a Brazilian population: evaluation and prevalence.
Einstein (Sao Paulo, Brazil)
Monteiro, Camila Ribeiro de Arruda CRA; Korkes, Fernando F; Krutman-Zveibil, Deborah D; Glina, Sidney S
FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma.
Bjui Compass
Adib, Elio E; El Zarif, Talal T; Jain, Rohit K RK; Skelton, William P WP; Freeman, Dory D; Curran, Catherine C; Akl, Elie E; Nassar, Amin H AH; Ravi, Praful P; Mantia, Charlene C; Kwiatkowski, David J DJ; Choueiri, Toni K TK; Sonpavde, Guru G
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment.
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma.
Npj Precision Oncology
Bitzer, Michael M; Spahn, Stephan S; Babaei, Sepideh S; Horger, Marius M; Singer, Stephan S; Schulze-Osthoff, Klaus K; Missios, Pavlos P; Gatidis, Sergios S; Nann, Dominik D; Mattern, Sven S; Scheble, Veit V; Nikolaou, Konstantin K; Armeanu-Ebinger, Sorin S; Schulze, Martin M; Schroeder, Christopher C; Biskup, Saskia S; Beha, Janina J; Claassen, Manfred M; Ruhm, Kristina K; Poso, Antti A; Malek, Nisar P NP
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern.
Journal Of Pathology And Translational Medicine
Sanguedolce, Francesca F; Calò, Beppe B; Chirico, Marco M; Falagario, Ugo U; Busetto, Gian Maria GM; Zanelli, Magda M; Bisagni, Alessandra A; Zizzo, Maurizio M; Ascani, Stefano S; Carrieri, Giuseppe G; Cormio, Luigi L
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas.
The Oncologist
Huang, Richard S P RSP; Haberberger, James J; Harries, Lukas L; Severson, Eric E; Duncan, Daniel L DL; Ferguson, N Lynn NL; Hemmerich, Amanda A; Edgerly, Claire C; Murugesan, Karthikeyan K; Xiao, Jinpeng J; McEwan, Deborah D; Holmes, Oliver O; Hiemenz, Matthew M; Venstrom, Jeffrey J; Elvin, Julia A JA; Creeden, James J; Lin, Douglas I DI; Ross, Jeffrey S JS; Ramkissoon, Shakti H SH